Kala Pharmaceuticals Adds 6% In Morning Trade

On:

Shares of Kala Pharmaceuticals, Inc. (KALA) are rising more than 6% Friday morning at $16.43.

The company today said Combangio, Inc., a unit of Kala, has been awarded a $15 million grant by the California Institute for Regenerative Medicine (CIRM) to support the company’s ongoing study of KPI-012 for the treatment of persistent corneal epithelial defect (PCED).

KALA has traded in the range of $3.54-$56.72 in the last 1 year.

Source: Read Full Article

Lates News:
  1. $940 Million in Bitcoin Move off Coinbase, Fueling Speculation a Whale Is Accumulating $BTC
  2. Hibbett Shares Rally On Better-than-expected Q2 Earnings
  3. Bitcoin Spot ETFs: Firm Eyes 70k+ BTC Inflows, This Price Target
  4. MicroStrategy Snapped Up $593 Million Worth Of Bitcoin In November, Treasury Tops $6.6 Billion
  5. Comparing Two Crypto GIants: Ethereum vs Bitcoin